Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19.

ABSTRACT:

Background

The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as one of the biggest health threats of our generation. A significant portion of patients are presenting with delirium and neuropsychiatric sequelae of the disease. Unique examination findings and responses to treatment have been identified.

Objective

In this article, we seek to provide pharmacologic and treatment recommendations specific to delirium in patients with COVID-19.

Methods

We performed a literature search reviewing the neuropsychiatric complications and treatments in prior coronavirus epidemics including Middle Eastern respiratory syndrome and severe acute respiratory syndrome coronaviruses, as well as the emergi

SUBMITTER: Baller EB 

PROVIDER: S-EPMC7240270 | biostudies-literature | 2020 Nov - Dec

REPOSITORIES: biostudies-literature